nigericin has been researched along with fluticasone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cipollina, C; Di Sano, C; Di Vincenzo, S; Gjomarkaj, M; Pace, E; Siena, L | 1 |
1 other study(ies) available for nigericin and fluticasone
Article | Year |
---|---|
17-oxo-DHA displays additive anti-inflammatory effects with fluticasone propionate and inhibits the NLRP3 inflammasome.
Topics: Aged; Anti-Inflammatory Agents; Case-Control Studies; Caspase 1; Cell Line; Cell Separation; Docosahexaenoic Acids; Enzyme Activation; Female; Fluticasone; Humans; Inflammasomes; Interleukin-1beta; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Mitochondria; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Proteolysis; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Receptors, Glucocorticoid; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2016 |